Published in J Biol Chem on August 10, 2001
Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J (2003) 2.99
Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. Structure (2004) 1.97
Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials (2008) 1.82
Interdomain tilt angle determines integrin-dependent function of the ninth and tenth FIII domains of human fibronectin. J Biol Chem (2004) 1.10
The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha. J Clin Endocrinol Metab (2002) 1.00
The solution structure of the invasive tip complex from Afa/Dr fibrils. Mol Microbiol (2006) 0.95
Guiding epithelial cell phenotypes with engineered integrin-specific recombinant fibronectin fragments. Tissue Eng Part A (2010) 0.94
Synergistic activity of the ninth and tenth FIII domains of human fibronectin depends upon structural stability. J Biol Chem (2002) 0.93
Novel mutant human fibronectin FIII9-10 domain pair with increased conformational stability and biological activity. Protein Eng (2002) 0.92
Using self-assembled monolayers to model cell adhesion to the 9th and 10th type III domains of fibronectin. Langmuir (2009) 0.92
Recombinant fibronectin matrix mimetics specify integrin adhesion and extracellular matrix assembly. Tissue Eng Part A (2012) 0.91
Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification. J Biomed Mater Res A (2009) 0.90
alpha(5)beta(1) Integrin Ligand PHSRN Induces Invasion and alpha(5) mRNA in Endothelial Cells to Stimulate Angiogenesis. Transl Oncol (2009) 0.84
Chemical and physical properties of carbonated hydroxyapatite affect breast cancer cell behavior. Acta Biomater (2015) 0.83
Collective cell migration on artificial extracellular matrix proteins containing full-length fibronectin domains. Adv Mater (2010) 0.78
Integrin α3β1 Binding to Fibronectin Is Dependent on the Ninth Type III Repeat. J Biol Chem (2015) 0.75
Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci U S A (1998) 3.55
The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell (1992) 3.20
Structure and distribution of modules in extracellular proteins. Q Rev Biophys (1996) 3.10
Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med (2010) 2.55
Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell (1996) 2.40
Structure of domain 1 of rat T lymphocyte CD2 antigen. Nature (1991) 2.31
Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. Cell (1993) 2.20
Human erythrocyte metabolism studies by 1H spin echo NMR. FEBS Lett (1977) 1.98
Protein modules. Trends Biochem Sci (1991) 1.95
The solution structure of human epidermal growth factor. Nature (1987) 1.94
A comparison of the folding kinetics and thermodynamics of two homologous fibronectin type III modules. J Mol Biol (1997) 1.89
Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase. Nature (1992) 1.86
Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell (1996) 1.85
NMR analysis of structure and dynamics of the cytosolic tails of integrin alpha IIb beta 3 in aqueous solution. Biochemistry (2001) 1.76
Application of spin-echo nuclear magnetic resonance to whole-cell systems. Membrane transport. Biochem J (1979) 1.73
Temperature dependent molecular motion of a tyrosine residue of ferrocytochrome C. FEBS Lett (1976) 1.73
Pulse methods for the simplification of protein NMR spectra. FEBS Lett (1975) 1.72
Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J Biol Chem (1996) 1.71
Solution structure of a pair of complement modules by nuclear magnetic resonance. J Mol Biol (1993) 1.68
Key residues involved in calcium-binding motifs in EGF-like domains. Nature (1991) 1.68
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function. Exp Neurol (2012) 1.62
Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry (1995) 1.61
The folding kinetics and thermodynamics of the Fyn-SH3 domain. Biochemistry (1998) 1.52
Module-module interactions in the cell binding region of fibronectin: stability, flexibility and specificity. J Mol Biol (1997) 1.52
Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J Biol Chem (1997) 1.51
Short selective pulses for biochemical applications. J Magn Reson B (1995) 1.49
Rapid refolding of a proline-rich all-beta-sheet fibronectin type III module. Proc Natl Acad Sci U S A (1996) 1.49
The structure of melittin. A 1H-NMR study in methanol. Eur J Biochem (1988) 1.49
High-resolution 1H NMR study of the solution structure of alamethicin. Biochemistry (1987) 1.49
Three-dimensional structure of a complement control protein module in solution. J Mol Biol (1991) 1.44
Drosophila dumpy is a gigantic extracellular protein required to maintain tension at epidermal-cuticle attachment sites. Curr Biol (2000) 1.42
Fibronectin structure and assembly. Curr Opin Cell Biol (1994) 1.40
Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. Biochemistry (1994) 1.36
Structure and function of fibronectin modules. Matrix Biol (1996) 1.34
Pulsed NMR methods for the observation and assignment of exchangeable hydrogens: application to bacitracin. FEBS Lett (1974) 1.32
Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor. Biochem J (1995) 1.32
The conformation of calreticulin is influenced by the endoplasmic reticulum luminal environment. J Biol Chem (2000) 1.31
Contribution of proline-14 to the structure and actions of melittin. FEBS Lett (1991) 1.30
Folding kinetics of the SH3 domain of PI3 kinase by real-time NMR combined with optical spectroscopy. J Mol Biol (1998) 1.29
Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics. Biochemistry (1991) 1.28
The first EGF-like domain from human factor IX contains a high-affinity calcium binding site. EMBO J (1990) 1.26
The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases. J Biol Chem (2001) 1.21
SH3 domains. Molecular 'Velcro'. Curr Biol (1994) 1.21
Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ (2001) 1.20
Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry (1992) 1.17
Proton magnetic resonance studies of the tyrosine residues of hen lysozyme-assignment and detection of conformational mobility. Proc R Soc Lond B Biol Sci (1975) 1.15
Secondary structure of human interleukin 2 from 3D heteronuclear NMR experiments. Biochemistry (1992) 1.15
Solution structure of SpoIIAA, a phosphorylatable component of the system that regulates transcription factor sigmaF of Bacillus subtilis. Proc Natl Acad Sci U S A (1998) 1.14
Endometriosis in monozygotic twins. Fertil Steril (1997) 1.13
The hairpin structure of the (6)F1(1)F2(2)F2 fragment from human fibronectin enhances gelatin binding. EMBO J (2001) 1.13
N.m.r. studies of red cells. Philos Trans R Soc Lond B Biol Sci (1980) 1.13
Secondary structure of a complement control protein module by two-dimensional 1H NMR. Biochemistry (1991) 1.11
The application of high resolution nuclear magnetic resonance to biological systems. Methods Biochem Anal (1979) 1.11
1H NMR assignment and secondary structure of the cell adhesion type III module of fibronectin. Biochemistry (1992) 1.11
Proton nuclear magnetic resonance of intact Friend leukemia cells: phosphorylcholine increase during differentiation. Science (1982) 1.10
NMR studies of a viral protein that mimics the regulators of complement activation. J Mol Biol (1997) 1.09
Four-helix bundle growth factors and their receptors: protein-protein interactions. Curr Opin Struct Biol (1995) 1.09
Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev Genet (1997) 1.09
Solution structure and peptide binding of the SH3 domain from human Fyn. Structure (1996) 1.08
NMR analysis of interacting soluble forms of the cell-cell recognition molecules CD2 and CD48. Biochemistry (1996) 1.07
Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J Biol Chem (1998) 1.06
Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry (1991) 1.06
A study of the histidine residues of human carbonic anhydrase B using 270 MHz proton magnetic resonance. J Mol Biol (1974) 1.04
An assessment of postoperative oxygen therapy in patients with fractured neck of femur. Anaesth Intensive Care (1988) 1.04
Human epidermal growth factor. High resolution solution structure and comparison with human transforming growth factor alpha. J Mol Biol (1992) 1.03
The effects of guanidine hydrochloride on the 'random coil' conformations and NMR chemical shifts of the peptide series GGXGG. J Biomol NMR (1997) 1.03
Solution structure of a pair of fibronectin type 1 modules with fibrin binding activity. J Mol Biol (1994) 1.01
The study of conformational states of proteins by nuclear magnetic resonance. Biochem J (1985) 1.01
Structure of the fibronectin type 1 module. Nature (1990) 1.00
The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator. Biochim Biophys Acta (1995) 1.00
The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity. Structure (1997) 1.00
High resolution 1H NMR study of the solution structure of the S4 segment of the sodium channel protein. FEBS Lett (1989) 0.99
Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet (2000) 0.99
Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours. Br J Surg (1992) 0.99
The solution structure of human transforming growth factor alpha. Eur J Biochem (1991) 0.99
Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain. Structure (1997) 0.98
A high resolution 1H NMR study of the solution structure of human epidermal growth factor. FEBS Lett (1986) 0.98
A 1H-NMR study of the activity expressed by lactate dehydrogenase in the human erythrocyte. Eur J Biochem (1986) 0.98
Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. Mol Hum Reprod (2001) 0.97
Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod (2000) 0.97
Observation of carbon labelling in cell metabolites using proton spin echo NMR. Biochem Biophys Res Commun (1982) 0.96
Alternative modes of tyrosyl phosphopeptide binding to a Src family SH2 domain: implications for regulation of tyrosine kinase activity. Biochemistry (1996) 0.96
Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase. Biochemistry (1996) 0.96
Three dimensional structure of the transmembrane region of the proto-oncogenic and oncogenic forms of the neu protein. EMBO J (1992) 0.96
Activity, disulphide mapping and structural modelling of the fifth domain of human beta 2-glycoprotein I. FEBS Lett (1992) 0.95
The solution structure of the F42A mutant of human interleukin 2. J Mol Biol (1995) 0.95
Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm (2010) 0.95
Enzyme-substrate and enzyme-inhibitor complexes of triose phosphate isomerase studied by 31P nuclear magnetic resonance. Biochem J (1979) 0.93
Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation. Biochemistry (1998) 0.93
High-resolution 1H NMR study of the solution structure of delta-hemolysin. Biochemistry (1988) 0.93
Localization and characterization of the hyaluronan-binding site on the link module from human TSG-6. Structure (2000) 0.93
Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance. J Mol Biol (1992) 0.93
Dynamic studies of a fibronectin type I module pair at three frequencies: Anisotropic modelling and direct determination of conformational exchange. J Biomol NMR (1996) 0.92
The role of electrostatics in protein-protein interactions of a monoclonal antibody. Mol Pharm (2014) 0.92
Studies of the histidine residues of triose phosphate isomerase by proton magnetic resonance and x-ray crystallography. J Mol Biol (1976) 0.92